查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1490273

个人化精神病学市场，按产品类型、治疗领域、最终用户、技术、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Personalized Psychiatry Market, By Product Type, By Therapeutic Areas, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年个人化精神医学市场规模为42.0943亿美元，2024年至2032年复合年增长率为11.98%。

个人化精神医学市场-市场动态

精神健康疾病盛行率上升

精神健康疾病发生率的不断上升极大地推动了个人化精神病学市场的发展。个人化精神病学根据每位患者的个人特征制定治疗计划，作为对复杂多变的心理健康状况的回应，正在受到越来越多的关注。越来越多的人被诊断出患有忧郁症、焦虑症、躁郁症和精神分裂症等精神健康问题，这是一个主要驱动因素。世界卫生组织 (WHO) 报告称，忧郁症是全球残疾的主要原因，影响超过 2.64 亿人。人们对心理健康问题的日益认识以及对寻求帮助的污名化正在导致诊断率的提高。数位健康平台和行动健康应用程式的兴起透过提供持续监控和即时资料收集来促进个人化护理。

个人化精神医学市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 11.98% 左右的复合年增长率成长

根据产品类型细分，Genomics 预计将在 2023 年显示最大的市场份额

根据治疗领域细分，忧郁和焦虑是2023年的主导类型

根据最终用户细分，医疗保健提供者是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

个人化精神医学市场細項分析：

全球个人化精神病学市场根据产品类型、治疗领域、最终用户、技术和地区进行细分。

根据产品类型，市场分为三类：基因组学、数位治疗和软体。由于数位设备在医疗保健领域的使用不断增加，基因组学类别将在 2023 年占据最大的市场份额，而数位治疗领域预计在未来几年将以最快的速度发展。由于基因组技术的发展，现在可以识别与精神疾病相关的遗传差异，这为客製化治疗计划打开了大门。

根据治疗领域，市场分为五类：忧郁症、焦虑症、躁郁症、成瘾症和其他。到2023年，忧郁症和焦虑症的市场预计将达到相当大的规模，并且在接下来的几年里，预计成长速度会更快。对各种疾病之间的变异性的不断加深的了解，以及不同人的不同根本原因和治疗结果。这种理解增加了对个体化诊断和治疗方法的需求。

个人化精神病学市场 - 地理洞察

北美心理健康问题日益普遍，推动了对个人化精神干预措施的需求。此外，该地区拥有出色的研究和医疗基础设施，支援个人化医疗策略的创建和采用。此外，政府对医疗保健创新以及法规和措施的大力投资鼓励了北美个人化精神病学市场的扩张。预计亚太地区个人化精神病学市场将以最快的速度成长。这一增长的推动因素包括扩大医疗技术投资、提高对心理健康问题的认识以及发展医疗基础设施。

个人化精神医学市场-竞争格局：

主要製药公司越来越多地投资于个人化精神病学。他们正在根据遗传和生物标记资讯开发定製药物。强生（Johnson & Johnson）、辉瑞（Pfizer）和罗氏（Roche）等公司在这一领域表现突出。生物技术公司处于开发创新诊断工具和疗法的前沿。他们通常专注于利基领域并利用尖端技术。例子包括 Myriad Genetics、Genomind 和 Assurex Health。製药公司、生技公司、学术机构和技术供应商之间的合作趋势日益明显。这些合作关係对于推进研究并将新的个人化疗法推向市场至关重要。例如，2024年5月，最重要的精神病治疗和调查平台Osmind宣布与美国精神病学协会（APA）建立突破性合作伙伴关係，以推进基于测量的护理（MBC）的实施以及精神病学的精准治疗。

最近的发展：

2021 年 8 月，MindMed 宣布与 Florian 合作，推动焦虑症个人化精神病学的发展。 Florian 在 RWE 和结果研究方面拥有丰富的领域经验，并开发了各种资讯产品来服务医疗保健产业。

2024 年 5 月，UAB 透过与高级实践提供者合作扩大了心理健康服务的覆盖范围。他们在满足社区对专业、有能力和独特的富有同情心的心理健康服务的巨大需求方面发挥着关键作用。

目录

第一章：个人化精神病学市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的个人化精神医学市场片段
    • 按治疗领域分類的个人化精神医学市场片段
    • 最终用户的个人化精神病学市场片段
    • 按技术分類的个人化精神病学市场片段
    • 按国家/地区分類的个人化精神病学市场摘要
    • 按地区分類的个人化精神医学市场片段
  • 竞争洞察

第 3 章：个人化精神医学主要市场趋势

  • 个性化精神病学市场驱动因素
    • 市场驱动因素的影响分析
  • 个人化精神医学市场限制
    • 市场限制影响分析
  • 个人化精神医学市场机会
  • 个性化精神病学市场未来趋势

第 4 章：个人化精神医学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：个人化精神医学市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：个人化精神医学市场格局

  • 个人化精神病学市场份额分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：个人化精神医学市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 基因组学
    • 数位治疗
    • 软体

第 8 章：个人化精神医学市场 - 按治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 忧郁和焦虑
    • 双极性情感障碍
    • 瘾
    • 其他的

第 9 章：个人化精神医学市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 心理健康专家
    • 患者
    • 医疗保健机构

第 10 章：个人化精神医学市场 - 按技术

  • 概述
    • 按技术分類的细分市场份额分析
    • 定序
    • 聚合酶炼式反应
    • 微阵列
    • 免疫分析
    • 其他的

第 11 章：个人化精神医学市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美个性化精神病学主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模与预测（按治疗领域）
    • 北美市场规模和预测（按最终用户）
    • 北美市场规模和预测（按技术）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲个性化精神病学主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按治疗领域）
    • 欧洲市场规模和预测（按最终用户）
    • 欧洲市场规模与预测（按技术）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区个人化精神病学主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 按治疗领域分類的亚太市场规模和预测
    • 亚太地区市场规模和预测（按最终用户）
    • 亚太地区市场规模与预测（按技术）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲个性化精神病学主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按治疗领域）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 拉丁美洲市场规模与预测（按技术）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲个人化精神病学主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 中东和非洲市场规模和预测（按最终用户）
    • 中东和非洲市场规模及预测（按技术）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 个人化精神病学产业

  • 竞争仪表板
  • 公司简介
    • GreyBird Ventures
    • Sunovion Pharmaceuticals Inc.
    • HMNC Holding GmbH
    • Arcara Personalized Psychiatry
    • Starling Minds
    • Karuna Therapeutics
    • CBT Plus
    • AltheaDx, Inc.
    • WayForward
    • BrightQuest
    • Peak Mental Wellness
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2847

REPORT HIGHLIGHT

Personalized Psychiatry Market size was valued at USD 4,209.43 million in 2023, expanding at a CAGR of 11.98% from 2024 to 2032.

The growing incidence of conditions like depression, anxiety, bipolar disorder, and schizophrenia necessitates more effective and personalized treatment methods. Increasing understanding of the genetic basis of psychiatric disorders is enabling more personalized treatment approaches. The development and implementation of personalized treatment plans can be expensive, limiting accessibility for some patients. International efforts to address the global mental health crisis can support the development and dissemination of personalized psychiatry approaches.

Personalized Psychiatry Market- Market Dynamics

Rising Prevalence of Mental Health Disorders

The growing incidence of mental health disorders is significantly propelling the personalized psychiatry market. Personalized psychiatry, which tailors treatment plans to the individual characteristics of each patient, is gaining traction as a response to the complex and varied nature of mental health conditions. The rising number of individuals diagnosed with mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia is a primary driver. The World Health Organization (WHO) reports that depression is a leading cause of disability worldwide, affecting over 264 million people. The growing recognition of mental health issues and the destigmatization of seeking help are contributing to higher diagnosis rates. The rise of digital health platforms and mobile health applications is facilitating personalized care by providing continuous monitoring and real-time data collection.

Personalized Psychiatry Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.98% over the forecast period (2024-2032)

Based on product type segmentation, Genomics was predicted to show maximum market share in the year 2023

Based on therapeutic areas segmentation, Depression and Anxiety was the leading type in 2023

Based on end users segmentation, Healthcare Providers was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Personalized Psychiatry Market- Segmentation Analysis:

The Global Personalized Psychiatry Market is segmented based on Product Type, therapeutic areas, End-user, Technology, and Region.

The market is divided into three categories based on product type: Genomics, Digital Therapeutics, and Software. Due to the rise in the use of digital devices in the healthcare sector, the genomics category holds the largest market share in 2023, while the digital therapeutics segment is predicted to develop at the quickest rate in the upcoming years. Thanks to developments in genomic technologies, it is now possible to identify genetic differences linked to psychiatric diseases, which opens the door to customized treatment plans.

The market is divided into five categories based on therapeutic areas: Depression, Anxiety, Bipolar Disorders, Addiction, and Others. In 2023, the market for depression and anxiety is expected to reach a sizeable amount, and in the ensuing years, it is expected to grow even faster. the expanding understanding of the variability among various illnesses, with different underlying causes and treatment outcomes for different people. This understanding has increased the need for individualized methods of diagnosis and therapy.

Personalized Psychiatry Market- Geographical Insights

The need for individualized psychiatric interventions is being driven by the increasing prevalence of mental health issues in North America. Furthermore, the area has excellent research and healthcare infrastructure, which supports the creation and uptake of personalized medicine strategies. Furthermore, strong investments in healthcare innovation and regulations and initiatives from the government encourage the expansion of the personalized psychiatry market in North America. The personalized psychiatry market is anticipated to grow at the quickest rate in the Asia-Pacific area. This rise is driven by elements including expanding investments in healthcare technology, raising awareness of mental health issues, and developing healthcare infrastructure.

Personalized Psychiatry Market- Competitive Landscape:

Major pharmaceutical companies are increasingly investing in personalized psychiatry. They are developing tailored medications based on genetic and biomarker information. Companies like Johnson & Johnson, Pfizer, and Roche are prominent in this space. Biotechnology companies are at the forefront of developing innovative diagnostic tools and therapies. They often focus on niche areas and leverage cutting-edge technologies. Examples include Myriad Genetics, Genomind, and Assurex Health. There is a growing trend of collaborations between pharmaceutical companies, biotech firms, academic institutions, and technology providers. These partnerships are essential for advancing research and bringing new personalized therapies to market. For instance, in May 2024, Osmind, the foremost psychiatric handling and investigate platform, publicized a ground-breaking partnership with the American Psychiatric Association (APA) to advance the implementation of measurement-based care (MBC) as well as precision dealing in psychiatry.

Recent Developments:

In August 2021, MindMed announced a collaboration with Florian to advance the development of personalized psychiatry for anxiety disorders. Florian has deep domain experience in RWE and outcomes studies and has developed a variety of information products to serve the healthcare industry.

In May 2024, UAB expanded access to mental health services through advanced practice provider collaborations. They are playing a critical role in meeting the community's overwhelming need for professional, competent, and uniquely compassionate mental health services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED PSYCHIATRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GreyBird Ventures

Sunovion Pharmaceuticals Inc.

HMNC Holding GmbH

Arcara Personalized Psychiatry

Starling Minds

Karuna Therapeutics

CBT Plus

AltheaDx, Inc.

WayForward

BrightQuest

Peak Mental Wellness

Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Genomics
  • Digital Therapeutics
  • Software

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY THERAPEUTIC AREAS - MARKET ANALYSIS, 2019 - 2032

  • Depression and Anxiety
  • Bipolar Disorders
  • Addiction
  • Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032

  • Mental Health Professionals
  • Patients
  • Healthcare Providers

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Sequencing
  • Polymerase Chain Reaction
  • Microarray
  • Immunoassay
  • Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Personalized Psychiatry Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Personalized Psychiatry Market Snippet by Product Type
    • 2.1.2.Personalized Psychiatry Market Snippet by Therapeutic Areas
    • 2.1.3.Personalized Psychiatry Market Snippet by End User
    • 2.1.4.Personalized Psychiatry Market Snippet by Technology
    • 2.1.5.Personalized Psychiatry Market Snippet by Country
    • 2.1.6.Personalized Psychiatry Market Snippet by Region
  • 2.2.Competitive Insights

3.Personalized Psychiatry Key Market Trends

  • 3.1.Personalized Psychiatry Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Personalized Psychiatry Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Personalized Psychiatry Market Opportunities
  • 3.4.Personalized Psychiatry Market Future Trends

4.Personalized Psychiatry Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Personalized Psychiatry Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Personalized Psychiatry Market Landscape

  • 6.1.Personalized Psychiatry Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Personalized Psychiatry Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Genomics
    • 7.1.3.Digital Therapeutics
    • 7.1.4.Software

8.Personalized Psychiatry Market - By Therapeutic Areas

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Therapeutic Areas, 2023 & 2032 (%)
    • 8.1.2.Depression and Anxiety
    • 8.1.3.Bipolar Disorders
    • 8.1.4.Addiction
    • 8.1.5.Others

9.Personalized Psychiatry Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Mental Health Professionals
    • 9.1.3.Patients
    • 9.1.4.Healthcare Providers

10.Personalized Psychiatry Market - By Technology

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 10.1.2.Sequencing
    • 10.1.3.Polymerase Chain Reaction
    • 10.1.4.Microarray
    • 10.1.5.Immunoassay
    • 10.1.6.Others

11.Personalized Psychiatry Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Personalized Psychiatry Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Personalized Psychiatry Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Personalized Psychiatry Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Personalized Psychiatry Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Personalized Psychiatry Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Personalized Psychiatry Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.GreyBird Ventures
    • 12.2.2.Sunovion Pharmaceuticals Inc.
    • 12.2.3.HMNC Holding GmbH
    • 12.2.4.Arcara Personalized Psychiatry
    • 12.2.5.Starling Minds
    • 12.2.6.Karuna Therapeutics
    • 12.2.7.CBT Plus
    • 12.2.8.AltheaDx, Inc.
    • 12.2.9.WayForward
    • 12.2.10.BrightQuest
    • 12.2.11.Peak Mental Wellness
    • 12.2.12.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Personalized Psychiatry Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Personalized Psychiatry Market, by Product Type 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Therapeutic Areas Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Areas
  • TABLE Global Personalized Psychiatry Market, by Therapeutic Areas 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Personalized Psychiatry Market, by End User 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Personalized Psychiatry Market, by Technology 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Personalized Psychiatry Market, by Region 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)